Fennec Pharmaceuticals drops 3.2% January 09, 2019 17:00 EST
CANADIAN DAILY STOCK REPORT
Fennec Pharmaceuticals Inc. (TSX:FRX), Canada's 10th largest Biotechnology company by market cap, has dropped 31.0c (3.2%) from its last trading session of January 08 to close at CAD9.34. Compared with the S&P/TSX 60 Index which rose 11.5 points (1.3%) in the day, the relative price change was -4.5%. The volume was 0.01 times the average daily trading volume of 42,235 shares. Its MCap is CAD178.4 million (US$134.8 million).
Highlights in today's Report:
SECTION 1 BEARISH SI...